650 related articles for article (PubMed ID: 18573148)
21. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia.
Dimai HP; Domej W; Leb G; Lau KH
J Bone Miner Res; 2001 Nov; 16(11):2132-41. PubMed ID: 11697811
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
23. [Bone mineral density in patients on long-term therapy with levothyroxine].
Korsić M; Cvijetić S; Dekanić-Ozegović D; Bolanća S; Kozić B
Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
25. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD
Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
[TBL] [Abstract][Full Text] [Related]
26. Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study.
Silva DR; Coelho AC; Dumke A; Valentini JD; de Nunes JN; Stefani CL; da Silva Mendes LF; Knorst MM
Respir Care; 2011 Jul; 56(7):961-8. PubMed ID: 21352667
[TBL] [Abstract][Full Text] [Related]
27. Effects of inhaled glucocorticoids on bone density in premenopausal women.
Israel E; Banerjee TR; Fitzmaurice GM; Kotlov TV; LaHive K; LeBoff MS
N Engl J Med; 2001 Sep; 345(13):941-7. PubMed ID: 11575285
[TBL] [Abstract][Full Text] [Related]
28. Low bone mineral density is related to severity of chronic obstructive pulmonary disease.
Kjensli A; Mowinckel P; Ryg MS; Falch JA
Bone; 2007 Feb; 40(2):493-7. PubMed ID: 17049326
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.
Bauer M; Fairbanks L; Berghöfer A; Hierholzer J; Bschor T; Baethge C; Rasgon N; Sasse J; Whybrow PC
J Affect Disord; 2004 Dec; 83(2-3):183-90. PubMed ID: 15555712
[TBL] [Abstract][Full Text] [Related]
30. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
Chou SH; Chen YW; Chuang HY; Kao EL; Huang MF
J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
[TBL] [Abstract][Full Text] [Related]
31. Bone mineral density and turnover in children with systemic juvenile chronic arthritis.
Brik R; Keidar Z; Schapira D; Israel O
J Rheumatol; 1998 May; 25(5):990-2. PubMed ID: 9598904
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term inhaled steroid use on bone mineral density in asthma patients.
Tug T; Kamanli A; Tug E
J Investig Allergol Clin Immunol; 2001; 11(4):300-2. PubMed ID: 11908820
[TBL] [Abstract][Full Text] [Related]
33. [Effect of physical activity on bone turnover in young boys].
Kalaï E; Bahlous A; Nbigh A; Sahli H; Sellami S; Abdelmoula J
Ann Biol Clin (Paris); 2007; 65(5):519-24. PubMed ID: 17913670
[TBL] [Abstract][Full Text] [Related]
34. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
35. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density in women with sarcoidosis.
Sipahi S; Tuzun S; Ozaras R; Calis HT; Ozaras N; Tuzun F; Karayel T
J Bone Miner Metab; 2004; 22(1):48-52. PubMed ID: 14691687
[TBL] [Abstract][Full Text] [Related]
37. [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].
Miazgowski T; Andrysiak-Mamos E; Pynka S; Gulińska M; Czekalski S
Przegl Lek; 1997; 54(7-8):533-9. PubMed ID: 9480464
[TBL] [Abstract][Full Text] [Related]
38. [Age-related change of bone biochemical markers and their relationships to mineral density in healthy Chinese men].
Zhao Q; Shen LX; Zhang H; Wu XP; Xie H; Shan PF; Cao XZ; Liao EY; Luo XH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1957-61. PubMed ID: 17064589
[TBL] [Abstract][Full Text] [Related]
39. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
40. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
